Loading…
The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction
Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacologic insomnia treatments were more often prescribed treatments for ED. Sleep quality an...
Saved in:
| Published in: | European urology focus 2024-01, Vol.10 (1), p.139-145 |
|---|---|
| Main Authors: | , , , , , , , , , , , |
| Format: | Article |
| Language: | English |
| Subjects: | |
| Citations: | Items that this one cites Items that cite this one |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| cited_by | cdi_FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043 |
|---|---|
| cites | cdi_FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043 |
| container_end_page | 145 |
| container_issue | 1 |
| container_start_page | 139 |
| container_title | European urology focus |
| container_volume | 10 |
| creator | Belladelli, Federico Li, Shufeng Zhang, Chiyuan A. Del Giudice, Francesco Basran, Satvir Muncey, Wade Glover, Frank Seranio, Nicolas Fallara, Giuseppe Montorsi, Francesco Salonia, Andrea Eisenberg, Michael L. |
| description | Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacologic insomnia treatments were more often prescribed treatments for ED.
Sleep quality and duration have been investigated for their association with health. Insomnia affects up to one-third of adults and may impact male erectile function. In addition, medical treatments for insomnia (many of which are sedatives) may also affect erectile quality.
To investigate the association of erectile dysfunction (ED) in patients diagnosed with and treated for insomnia.
We utilized the IBM MarketScan (2007–2016) Commercial and Medicare Supplemental Databases (v 2.0). Age- and enrollment-matched controls were selected among patients without insomnia diagnosis or treatment.
Cox proportional hazard models were used to estimate the risk of incident ED (ie, diagnosis alone, or diagnosis and treatment with phosphodiesterase-5 inhibitors [PDE5i], intracavernous injection (ICI)/urethral suppositories, and penile prosthesis) after the diagnosis or treatment of insomnia while adjusting for relevant comorbidities.
In total, 539 109 men with an insomnia diagnosis were identified. Of these men, 356 575 were also medically treated for insomnia. The mean (±standard deviation) follow-up times for patients diagnosed with insomnia and those diagnosed with and treated for insomnia were 2.8 ± 1.6 and 3.1 ± 1.8 yr, respectively. Men with insomnia were more commonly smokers and had a higher number of office visits and comorbidities than controls (p |
| doi_str_mv | 10.1016/j.euf.2023.08.005 |
| format | article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2863764736</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S240545692300189X</els_id><sourcerecordid>2863764736</sourcerecordid><originalsourceid>FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043</originalsourceid><addsrcrecordid>eNp9kLFOwzAQhi0EolXpA7CgjAxNOMeOE4uplAKVimAos5XaF-GqTUqcgPr2OLRUTEx30n33S_9HyCWFiAIVN6sI2yKKIWYRZBFAckL6MYck5ImQp3_2Hhk6twIAmvCUZeyc9FgqJEia9cnr4h2DsXOVtnljqzK4w-YLsQxmpas2pc1Hxy14RmP1D-VGQV6aYFqjbuwag_udK9pSd6cLclbka4fDwxyQt4fpYvIUzl8eZ5PxPNQsYU0oMs1RZkCRSqOlyVkBVKZCZ0ZqEaMUS80YhURyZjg3CWqacowRkoLHwNmAXO9zt3X10aJr1MY6jet1XmLVOhVnwrf0hYVH6R7VdeVcjYXa1naT1ztFQXUu1Up5l6pzqSBT3qX_uTrEt8sNmuPHrzkP3O4B9CU_LdbKaYul9o46K8pU9p_4bwRUg1Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2863764736</pqid></control><display><type>article</type><title>The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction</title><source>ScienceDirect Freedom Collection 2022-2024</source><creator>Belladelli, Federico ; Li, Shufeng ; Zhang, Chiyuan A. ; Del Giudice, Francesco ; Basran, Satvir ; Muncey, Wade ; Glover, Frank ; Seranio, Nicolas ; Fallara, Giuseppe ; Montorsi, Francesco ; Salonia, Andrea ; Eisenberg, Michael L.</creator><creatorcontrib>Belladelli, Federico ; Li, Shufeng ; Zhang, Chiyuan A. ; Del Giudice, Francesco ; Basran, Satvir ; Muncey, Wade ; Glover, Frank ; Seranio, Nicolas ; Fallara, Giuseppe ; Montorsi, Francesco ; Salonia, Andrea ; Eisenberg, Michael L.</creatorcontrib><description>Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacologic insomnia treatments were more often prescribed treatments for ED.
Sleep quality and duration have been investigated for their association with health. Insomnia affects up to one-third of adults and may impact male erectile function. In addition, medical treatments for insomnia (many of which are sedatives) may also affect erectile quality.
To investigate the association of erectile dysfunction (ED) in patients diagnosed with and treated for insomnia.
We utilized the IBM MarketScan (2007–2016) Commercial and Medicare Supplemental Databases (v 2.0). Age- and enrollment-matched controls were selected among patients without insomnia diagnosis or treatment.
Cox proportional hazard models were used to estimate the risk of incident ED (ie, diagnosis alone, or diagnosis and treatment with phosphodiesterase-5 inhibitors [PDE5i], intracavernous injection (ICI)/urethral suppositories, and penile prosthesis) after the diagnosis or treatment of insomnia while adjusting for relevant comorbidities.
In total, 539 109 men with an insomnia diagnosis were identified. Of these men, 356 575 were also medically treated for insomnia. The mean (±standard deviation) follow-up times for patients diagnosed with insomnia and those diagnosed with and treated for insomnia were 2.8 ± 1.6 and 3.1 ± 1.8 yr, respectively. Men with insomnia were more commonly smokers and had a higher number of office visits and comorbidities than controls (p < 0.001). On an adjusted analysis, both untreated and treated insomnia were associated with increased risks of ED diagnosis (hazard ratio or HR [95% confidence interval {CI}]: 1.58 [1.54–1.62] and 1.66 [1.64–1.69], respectively; p < 0.001). Similarly, men with treated insomnia had a higher risk of having ED treated with PDE5i (HR [95% CI]: 1.52 [1.49–1.55]; p < 0.001) and ICI (HR [95% CI]: 1.32 [1.14–1.54]; p < 0.001) when compared with controls. A limitation of this study was that a lack of granularity regarding patient clinical characteristics (eg, severity of disease, laboratory data, etc.) is inherent to insurance claims data. In addition, the follow-up was limited and may affect associations at longer time points.
In the current report, a consistent association between insomnia and ED diagnosis was identified. Men diagnosed with insomnia only were found to have a higher risk of developing ED. Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED. Given the prevalence of insomnia, future studies are warranted to delineate the association of insomnia and its treatment with erectile function.
Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED.</description><identifier>ISSN: 2405-4569</identifier><identifier>EISSN: 2405-4569</identifier><identifier>DOI: 10.1016/j.euf.2023.08.005</identifier><identifier>PMID: 37690918</identifier><language>eng</language><publisher>Netherlands: Elsevier B.V</publisher><subject>Erectile dysfunction ; Erectile dysfunction treatment ; Insomnia ; Phosphodiesterase-5 inhibitors</subject><ispartof>European urology focus, 2024-01, Vol.10 (1), p.139-145</ispartof><rights>2023 European Association of Urology</rights><rights>Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043</citedby><cites>FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043</cites><orcidid>0000-0002-2165-659X</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37690918$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Belladelli, Federico</creatorcontrib><creatorcontrib>Li, Shufeng</creatorcontrib><creatorcontrib>Zhang, Chiyuan A.</creatorcontrib><creatorcontrib>Del Giudice, Francesco</creatorcontrib><creatorcontrib>Basran, Satvir</creatorcontrib><creatorcontrib>Muncey, Wade</creatorcontrib><creatorcontrib>Glover, Frank</creatorcontrib><creatorcontrib>Seranio, Nicolas</creatorcontrib><creatorcontrib>Fallara, Giuseppe</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Salonia, Andrea</creatorcontrib><creatorcontrib>Eisenberg, Michael L.</creatorcontrib><title>The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction</title><title>European urology focus</title><addtitle>Eur Urol Focus</addtitle><description>Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacologic insomnia treatments were more often prescribed treatments for ED.
Sleep quality and duration have been investigated for their association with health. Insomnia affects up to one-third of adults and may impact male erectile function. In addition, medical treatments for insomnia (many of which are sedatives) may also affect erectile quality.
To investigate the association of erectile dysfunction (ED) in patients diagnosed with and treated for insomnia.
We utilized the IBM MarketScan (2007–2016) Commercial and Medicare Supplemental Databases (v 2.0). Age- and enrollment-matched controls were selected among patients without insomnia diagnosis or treatment.
Cox proportional hazard models were used to estimate the risk of incident ED (ie, diagnosis alone, or diagnosis and treatment with phosphodiesterase-5 inhibitors [PDE5i], intracavernous injection (ICI)/urethral suppositories, and penile prosthesis) after the diagnosis or treatment of insomnia while adjusting for relevant comorbidities.
In total, 539 109 men with an insomnia diagnosis were identified. Of these men, 356 575 were also medically treated for insomnia. The mean (±standard deviation) follow-up times for patients diagnosed with insomnia and those diagnosed with and treated for insomnia were 2.8 ± 1.6 and 3.1 ± 1.8 yr, respectively. Men with insomnia were more commonly smokers and had a higher number of office visits and comorbidities than controls (p < 0.001). On an adjusted analysis, both untreated and treated insomnia were associated with increased risks of ED diagnosis (hazard ratio or HR [95% confidence interval {CI}]: 1.58 [1.54–1.62] and 1.66 [1.64–1.69], respectively; p < 0.001). Similarly, men with treated insomnia had a higher risk of having ED treated with PDE5i (HR [95% CI]: 1.52 [1.49–1.55]; p < 0.001) and ICI (HR [95% CI]: 1.32 [1.14–1.54]; p < 0.001) when compared with controls. A limitation of this study was that a lack of granularity regarding patient clinical characteristics (eg, severity of disease, laboratory data, etc.) is inherent to insurance claims data. In addition, the follow-up was limited and may affect associations at longer time points.
In the current report, a consistent association between insomnia and ED diagnosis was identified. Men diagnosed with insomnia only were found to have a higher risk of developing ED. Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED. Given the prevalence of insomnia, future studies are warranted to delineate the association of insomnia and its treatment with erectile function.
Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED.</description><subject>Erectile dysfunction</subject><subject>Erectile dysfunction treatment</subject><subject>Insomnia</subject><subject>Phosphodiesterase-5 inhibitors</subject><issn>2405-4569</issn><issn>2405-4569</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><recordid>eNp9kLFOwzAQhi0EolXpA7CgjAxNOMeOE4uplAKVimAos5XaF-GqTUqcgPr2OLRUTEx30n33S_9HyCWFiAIVN6sI2yKKIWYRZBFAckL6MYck5ImQp3_2Hhk6twIAmvCUZeyc9FgqJEia9cnr4h2DsXOVtnljqzK4w-YLsQxmpas2pc1Hxy14RmP1D-VGQV6aYFqjbuwag_udK9pSd6cLclbka4fDwxyQt4fpYvIUzl8eZ5PxPNQsYU0oMs1RZkCRSqOlyVkBVKZCZ0ZqEaMUS80YhURyZjg3CWqacowRkoLHwNmAXO9zt3X10aJr1MY6jet1XmLVOhVnwrf0hYVH6R7VdeVcjYXa1naT1ztFQXUu1Up5l6pzqSBT3qX_uTrEt8sNmuPHrzkP3O4B9CU_LdbKaYul9o46K8pU9p_4bwRUg1Q</recordid><startdate>202401</startdate><enddate>202401</enddate><creator>Belladelli, Federico</creator><creator>Li, Shufeng</creator><creator>Zhang, Chiyuan A.</creator><creator>Del Giudice, Francesco</creator><creator>Basran, Satvir</creator><creator>Muncey, Wade</creator><creator>Glover, Frank</creator><creator>Seranio, Nicolas</creator><creator>Fallara, Giuseppe</creator><creator>Montorsi, Francesco</creator><creator>Salonia, Andrea</creator><creator>Eisenberg, Michael L.</creator><general>Elsevier B.V</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2165-659X</orcidid></search><sort><creationdate>202401</creationdate><title>The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction</title><author>Belladelli, Federico ; Li, Shufeng ; Zhang, Chiyuan A. ; Del Giudice, Francesco ; Basran, Satvir ; Muncey, Wade ; Glover, Frank ; Seranio, Nicolas ; Fallara, Giuseppe ; Montorsi, Francesco ; Salonia, Andrea ; Eisenberg, Michael L.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Erectile dysfunction</topic><topic>Erectile dysfunction treatment</topic><topic>Insomnia</topic><topic>Phosphodiesterase-5 inhibitors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Belladelli, Federico</creatorcontrib><creatorcontrib>Li, Shufeng</creatorcontrib><creatorcontrib>Zhang, Chiyuan A.</creatorcontrib><creatorcontrib>Del Giudice, Francesco</creatorcontrib><creatorcontrib>Basran, Satvir</creatorcontrib><creatorcontrib>Muncey, Wade</creatorcontrib><creatorcontrib>Glover, Frank</creatorcontrib><creatorcontrib>Seranio, Nicolas</creatorcontrib><creatorcontrib>Fallara, Giuseppe</creatorcontrib><creatorcontrib>Montorsi, Francesco</creatorcontrib><creatorcontrib>Salonia, Andrea</creatorcontrib><creatorcontrib>Eisenberg, Michael L.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology focus</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Belladelli, Federico</au><au>Li, Shufeng</au><au>Zhang, Chiyuan A.</au><au>Del Giudice, Francesco</au><au>Basran, Satvir</au><au>Muncey, Wade</au><au>Glover, Frank</au><au>Seranio, Nicolas</au><au>Fallara, Giuseppe</au><au>Montorsi, Francesco</au><au>Salonia, Andrea</au><au>Eisenberg, Michael L.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction</atitle><jtitle>European urology focus</jtitle><addtitle>Eur Urol Focus</addtitle><date>2024-01</date><risdate>2024</risdate><volume>10</volume><issue>1</issue><spage>139</spage><epage>145</epage><pages>139-145</pages><issn>2405-4569</issn><eissn>2405-4569</eissn><abstract>Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacologic insomnia treatments were more often prescribed treatments for ED.
Sleep quality and duration have been investigated for their association with health. Insomnia affects up to one-third of adults and may impact male erectile function. In addition, medical treatments for insomnia (many of which are sedatives) may also affect erectile quality.
To investigate the association of erectile dysfunction (ED) in patients diagnosed with and treated for insomnia.
We utilized the IBM MarketScan (2007–2016) Commercial and Medicare Supplemental Databases (v 2.0). Age- and enrollment-matched controls were selected among patients without insomnia diagnosis or treatment.
Cox proportional hazard models were used to estimate the risk of incident ED (ie, diagnosis alone, or diagnosis and treatment with phosphodiesterase-5 inhibitors [PDE5i], intracavernous injection (ICI)/urethral suppositories, and penile prosthesis) after the diagnosis or treatment of insomnia while adjusting for relevant comorbidities.
In total, 539 109 men with an insomnia diagnosis were identified. Of these men, 356 575 were also medically treated for insomnia. The mean (±standard deviation) follow-up times for patients diagnosed with insomnia and those diagnosed with and treated for insomnia were 2.8 ± 1.6 and 3.1 ± 1.8 yr, respectively. Men with insomnia were more commonly smokers and had a higher number of office visits and comorbidities than controls (p < 0.001). On an adjusted analysis, both untreated and treated insomnia were associated with increased risks of ED diagnosis (hazard ratio or HR [95% confidence interval {CI}]: 1.58 [1.54–1.62] and 1.66 [1.64–1.69], respectively; p < 0.001). Similarly, men with treated insomnia had a higher risk of having ED treated with PDE5i (HR [95% CI]: 1.52 [1.49–1.55]; p < 0.001) and ICI (HR [95% CI]: 1.32 [1.14–1.54]; p < 0.001) when compared with controls. A limitation of this study was that a lack of granularity regarding patient clinical characteristics (eg, severity of disease, laboratory data, etc.) is inherent to insurance claims data. In addition, the follow-up was limited and may affect associations at longer time points.
In the current report, a consistent association between insomnia and ED diagnosis was identified. Men diagnosed with insomnia only were found to have a higher risk of developing ED. Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED. Given the prevalence of insomnia, future studies are warranted to delineate the association of insomnia and its treatment with erectile function.
Insomnia affects up to one-third of adults and impact male erectile function. Men only diagnosed with insomnia were found to have a higher risk of developing erectile dysfunction (ED). Moreover, men with pharmacological insomnia treatments were more often prescribed treatments for ED.</abstract><cop>Netherlands</cop><pub>Elsevier B.V</pub><pmid>37690918</pmid><doi>10.1016/j.euf.2023.08.005</doi><tpages>7</tpages><orcidid>https://orcid.org/0000-0002-2165-659X</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2405-4569 |
| ispartof | European urology focus, 2024-01, Vol.10 (1), p.139-145 |
| issn | 2405-4569 2405-4569 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2863764736 |
| source | ScienceDirect Freedom Collection 2022-2024 |
| subjects | Erectile dysfunction Erectile dysfunction treatment Insomnia Phosphodiesterase-5 inhibitors |
| title | The Association Between Insomnia, Insomnia Medications, and Erectile Dysfunction |
| url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T15%3A59%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Association%20Between%20Insomnia,%20Insomnia%20Medications,%20and%20Erectile%20Dysfunction&rft.jtitle=European%20urology%20focus&rft.au=Belladelli,%20Federico&rft.date=2024-01&rft.volume=10&rft.issue=1&rft.spage=139&rft.epage=145&rft.pages=139-145&rft.issn=2405-4569&rft.eissn=2405-4569&rft_id=info:doi/10.1016/j.euf.2023.08.005&rft_dat=%3Cproquest_cross%3E2863764736%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c353t-68c4e9801e19dc9da3f01976c8d9c62e96bc33105943d44d5ec174e2e05f42043%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2863764736&rft_id=info:pmid/37690918&rfr_iscdi=true |